Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.3.2.2 extracted from

  • Bergmann, J.F.; Vrolijk, J.M.; van der Schaar, P.; Vroom, B.; van Hoek, B.; van der Sluys Veer, A.; de Vries, R.A.; Verhey, E.; Hansen, B.E.; Brouwer, J.T.; Janssen, H.L.; Schalm, S.W.; de Knegt, R.J.
    gamma-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders (2007), Liver Int., 27, 1217-1225.
    View publication on PubMed

Application

Application Comment Organism
medicine retreatment with PegIFN-alpha-2b and ribavirin for a minimum of 48 weeks should be considered in all patients with chronic hepatitis C unresponsive to previous IFN-based therapies. Baseline gamma-glutamyltransferase values and rapid virological response are highly predictive for retreatment outcome Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-